Suppression of phospholipase C blocks G(i)-mediated inhibition of adenylyl cyclase activity

Guo Huang Fan, Tian Hua Zhou, Wenbo Zhang, Gang Pei

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The potential effect of inhibition of phospholipase C on the response of G(i)-coupled receptors was investigated in neuroblastoma x glioma hybrid (NG108-15) cells. The phospholipase C specific inhibitor 1-[6-((17β-3- methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]1H-pyrrole-2,5-dione (U73122), which did not affect basal and forskolin-stimulated adenylyl cyclase activities, time- and dose-dependently blocked δ-opioid receptor-mediated inhibition of adenylyl cyclase activity, the EC50 (0.5 μM) of which was consistent with that for inhibition of bradykinin-dependent phospholipase C activation (EC50 = 1 μM). U73122 treatment also blocked functional responses of m4 muscarinic receptor and α2-adrenoceptor in NG108-15 cells and three opioid receptors (μ, δ and opioid receptor-like receptor (ORL1)) in human neuroblastoma SK-N-SH cells. 1-[6-((17β-3-Methoxyestra-1,3,5(10)- trien-17-yl)amino)hexyl]-2,5-pyrrolidinedione (U73343), an inactive analog of U73122, did not show any effect, which suggests that the blockade by U73122 of G(i)-coupled receptor-mediated signaling is probably mediated through inhibition of phospholipase C, although a possible direct modification of G proteins can not be excluded. Furthermore, treatment with U73122 but not U73343 blocked the GTP-induced inhibition of adenylyl cyclase, indicating blockade at the level of G(i) proteins.

Original languageEnglish (US)
Pages (from-to)317-322
Number of pages6
JournalEuropean Journal of Pharmacology
Volume341
Issue number2-3
DOIs
StatePublished - Jan 12 1998
Externally publishedYes

Fingerprint

Type C Phospholipases
Adenylyl Cyclases
Opioid Receptors
Neuroblastoma
Succinimides
Muscarinic M4 Receptors
Trientine
Bradykinin
Colforsin
Guanosine Triphosphate
GTP-Binding Proteins
Glioma
Adrenergic Receptors
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
Proteins

Keywords

  • Adenylyl cyclase
  • G protein-coupled receptor
  • G(i) protein
  • Phospholipase C
  • Phospholipase C inhibitor

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Suppression of phospholipase C blocks G(i)-mediated inhibition of adenylyl cyclase activity. / Fan, Guo Huang; Zhou, Tian Hua; Zhang, Wenbo; Pei, Gang.

In: European Journal of Pharmacology, Vol. 341, No. 2-3, 12.01.1998, p. 317-322.

Research output: Contribution to journalArticle

Fan, Guo Huang ; Zhou, Tian Hua ; Zhang, Wenbo ; Pei, Gang. / Suppression of phospholipase C blocks G(i)-mediated inhibition of adenylyl cyclase activity. In: European Journal of Pharmacology. 1998 ; Vol. 341, No. 2-3. pp. 317-322.
@article{a18a297b6a564e2abe4887f19713f240,
title = "Suppression of phospholipase C blocks G(i)-mediated inhibition of adenylyl cyclase activity",
abstract = "The potential effect of inhibition of phospholipase C on the response of G(i)-coupled receptors was investigated in neuroblastoma x glioma hybrid (NG108-15) cells. The phospholipase C specific inhibitor 1-[6-((17β-3- methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]1H-pyrrole-2,5-dione (U73122), which did not affect basal and forskolin-stimulated adenylyl cyclase activities, time- and dose-dependently blocked δ-opioid receptor-mediated inhibition of adenylyl cyclase activity, the EC50 (0.5 μM) of which was consistent with that for inhibition of bradykinin-dependent phospholipase C activation (EC50 = 1 μM). U73122 treatment also blocked functional responses of m4 muscarinic receptor and α2-adrenoceptor in NG108-15 cells and three opioid receptors (μ, δ and opioid receptor-like receptor (ORL1)) in human neuroblastoma SK-N-SH cells. 1-[6-((17β-3-Methoxyestra-1,3,5(10)- trien-17-yl)amino)hexyl]-2,5-pyrrolidinedione (U73343), an inactive analog of U73122, did not show any effect, which suggests that the blockade by U73122 of G(i)-coupled receptor-mediated signaling is probably mediated through inhibition of phospholipase C, although a possible direct modification of G proteins can not be excluded. Furthermore, treatment with U73122 but not U73343 blocked the GTP-induced inhibition of adenylyl cyclase, indicating blockade at the level of G(i) proteins.",
keywords = "Adenylyl cyclase, G protein-coupled receptor, G(i) protein, Phospholipase C, Phospholipase C inhibitor",
author = "Fan, {Guo Huang} and Zhou, {Tian Hua} and Wenbo Zhang and Gang Pei",
year = "1998",
month = "1",
day = "12",
doi = "10.1016/S0014-2999(97)01477-5",
language = "English (US)",
volume = "341",
pages = "317--322",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Suppression of phospholipase C blocks G(i)-mediated inhibition of adenylyl cyclase activity

AU - Fan, Guo Huang

AU - Zhou, Tian Hua

AU - Zhang, Wenbo

AU - Pei, Gang

PY - 1998/1/12

Y1 - 1998/1/12

N2 - The potential effect of inhibition of phospholipase C on the response of G(i)-coupled receptors was investigated in neuroblastoma x glioma hybrid (NG108-15) cells. The phospholipase C specific inhibitor 1-[6-((17β-3- methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]1H-pyrrole-2,5-dione (U73122), which did not affect basal and forskolin-stimulated adenylyl cyclase activities, time- and dose-dependently blocked δ-opioid receptor-mediated inhibition of adenylyl cyclase activity, the EC50 (0.5 μM) of which was consistent with that for inhibition of bradykinin-dependent phospholipase C activation (EC50 = 1 μM). U73122 treatment also blocked functional responses of m4 muscarinic receptor and α2-adrenoceptor in NG108-15 cells and three opioid receptors (μ, δ and opioid receptor-like receptor (ORL1)) in human neuroblastoma SK-N-SH cells. 1-[6-((17β-3-Methoxyestra-1,3,5(10)- trien-17-yl)amino)hexyl]-2,5-pyrrolidinedione (U73343), an inactive analog of U73122, did not show any effect, which suggests that the blockade by U73122 of G(i)-coupled receptor-mediated signaling is probably mediated through inhibition of phospholipase C, although a possible direct modification of G proteins can not be excluded. Furthermore, treatment with U73122 but not U73343 blocked the GTP-induced inhibition of adenylyl cyclase, indicating blockade at the level of G(i) proteins.

AB - The potential effect of inhibition of phospholipase C on the response of G(i)-coupled receptors was investigated in neuroblastoma x glioma hybrid (NG108-15) cells. The phospholipase C specific inhibitor 1-[6-((17β-3- methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]1H-pyrrole-2,5-dione (U73122), which did not affect basal and forskolin-stimulated adenylyl cyclase activities, time- and dose-dependently blocked δ-opioid receptor-mediated inhibition of adenylyl cyclase activity, the EC50 (0.5 μM) of which was consistent with that for inhibition of bradykinin-dependent phospholipase C activation (EC50 = 1 μM). U73122 treatment also blocked functional responses of m4 muscarinic receptor and α2-adrenoceptor in NG108-15 cells and three opioid receptors (μ, δ and opioid receptor-like receptor (ORL1)) in human neuroblastoma SK-N-SH cells. 1-[6-((17β-3-Methoxyestra-1,3,5(10)- trien-17-yl)amino)hexyl]-2,5-pyrrolidinedione (U73343), an inactive analog of U73122, did not show any effect, which suggests that the blockade by U73122 of G(i)-coupled receptor-mediated signaling is probably mediated through inhibition of phospholipase C, although a possible direct modification of G proteins can not be excluded. Furthermore, treatment with U73122 but not U73343 blocked the GTP-induced inhibition of adenylyl cyclase, indicating blockade at the level of G(i) proteins.

KW - Adenylyl cyclase

KW - G protein-coupled receptor

KW - G(i) protein

KW - Phospholipase C

KW - Phospholipase C inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0032509751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032509751&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(97)01477-5

DO - 10.1016/S0014-2999(97)01477-5

M3 - Article

VL - 341

SP - 317

EP - 322

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -